UBS UK Equity Income C Acc
- Citicode
- G5QU
- Launch Date
- 15-08-2012
- Fund Size
- £313,169,727
- Yield
- 4.50%
- Ongoing Charge
- 0.59%
- Fund Managers
- Kevin Barker
Philip Haigh
Steven Magill
Fund Objective
The UBS UK Equity Income Fund (the "Fund") aims to generate income and grow the value of your investment; and outperform the FTSE All-Share Index the "Benchmark") after charges over the medium to long term (3 to 5 years). At least 80% of the Fund will be invested in shares of UK companies or non UK companies which are listed in the UK or which have significant trading activities in the UK. The Fund may also invest in other equities, bonds, warrants, money market instruments, deposits, currencies, cash and near cash and other funds, which may be managed by UBS. The Fund may use derivatives (financial instruments whose value is linked to an underlying asset or index) for investment purposes or efficient portfolio management. The Fund is actively managed, the strategy is to invest in equities believed to be undervalued by the market. Investors can buy or sell shares every UK working day. The income in respect of an accumulation share class is not distributed but is retained in the Fund and reflected in the share price. This Fund may not be appropriate for investors who plan to withdraw their money within 5 years of investment.
Top 10 Holdings
Asset Class
Fund Manager
Kevin Barker
Start Date
31-12-2021
Bio
-
Fund Manager
Philip Haigh
Start Date
30-06-2023
Bio
-
Fund Manager
Steven Magill
Start Date
29-04-2013
Bio
Steve Magill is head of the European Value team at UBS Asset Management, managing around $5 billion of UK equities and £2.4 billion of European equities. Magill initially joined UBS in 1986, before taking a career break to study. He re-joined after gaining a first class degree in accounting to UBS as a UK equity portfolio manager. Having successfully built a track record as a PM, Magill moved to a European healthcare role as a senior analyst, progressing rapidly to take on the role of deputy head of Pan-European Research in 2007 and leading the Global Healthcare team. Magill re-joined the UK Equity Value team in 2009 as part of a managed succession plan, becoming head of the team in 2015. In 2017 his responsibilities were extended to managing the European equity Value strategies. Magill is a regular member of the CFA Society of the UK and the CFA Institute.
Data source:
All financial data is supplied by FE

Disclaimer:
Investors buying funds through Rosan Select are specifically buying without investment advice. The value of investments can fall as well as rise, and the investor may not get back the original amounts invested. If you have any doubt about whether a fund purchase meets your expectations or risk criteria, then you should contact invest@rosan-ifa.com our office to seek specific guidance.